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Particulate matter (PM) is one of six dam-
aging air pollutants that has been identified 
under the Clean Air Act of 1970 and is regu-
lated for the sake of protecting human health. 
The harmful effects of outdoor PM have been 
well established and include premature death 
(Samet et al. 2000) and worsening of asthma 
morbidity (Mar et al. 2004; Pope et al. 1991; 
Rabinovitch et al. 2006; Romieu et al. 1996; 
Yu et al. 2000). The evidence of the effect of 
indoor PM on asthma health is not as well 
established. The indoor environment is espe-
cially important in the context of asthma 
because Americans spend most of their time 
indoors, and improvement of indoor air 
quality could therefore provide an important 
opportunity to better asthma health. Indoor 
PM differs from outdoor PM in concentra-
tion, source, and composition (Allen et al. 
2003; Long et al. 2000; Turpin et al. 2007; 
Wallace 1996; Wallace et al. 2003). Thus, we 
cannot simply extrapolate the health effects of 
indoor PM from studies of outdoor air.
Under the Clean Air Act of 1970, the 
National Ambient Air Quality Standards 
(NAAQS) have defined limits for acceptable 
daily and annual concentrations of out-
door PM < 2.5 µm and < 10 µm in diam-
eter (PM2.5 and PM10, respectively) [U.S. 
Environmental Protection Agency (EPA) 
1997]. More recently, there has been interest 
in developing standards for the coarse tho-
racic particles that are between 2.5 and 10 
µm in diameter (PM2.5–10), which, unlike 
PM10, do not include the PM2.5 (fine PM) 
fraction. In the recent 2006 NAAQS update, 
PM2.5 standards were made more stringent 
based on substantial scientific evidence of det-
rimental health effects (U.S. EPA 2006b). 
There was a simultaneous proposal to replace 
the existing daily PM10 standards with a 
PM2.5–10 (coarse PM) standard in urban areas 
only (U.S. EPA 2006b, 2006c). However, 
in the final NAAQS, the annual PM10 stan-
dard was revoked and the daily PM10 stan-
dard was retained without replacement by 
a PM2.5–10 standard because of lack of suf-
ficient evidence of adverse health effects. The 
U.S. EPA will continue to monitor PM2.5–10 
in sites throughout the United States and has 
recognized the need for further research on 
the health effects of coarse PM.
The National Research Council (2004) has 
outlined as a top research priority the identifi-
cation of subpopulations at risk of adverse 
health outcomes related to PM exposure. 
Inner-city African-American children incur a 
disproportionate burden of asthma morbidity 
compared with other U.S. children (American 
Lung Association 2005; Moorman et al. 
2007). Although there are many hypothesized 
contributors to the disparities in asthma mor-
bidity in the United States, including access 
to medical care, exposure to child care settings 
or other children, diet, and stress, exposure to 
environmental pollutants may play an impor-
tant role (Gold and Wright 2005). Inner-city 
African-American children with asthma may 
be a susceptible subpopulation because they 
are more likely to live in geographic areas with 
poor outdoor air quality (American Lung 
Association 2005), and ongoing exposure to 
home indoor air of suboptimal quality may 
confer additional risk to asthma health. The 
goal of the present study was to investigate the 
effect of in-home coarse and fine PM on respi-
ratory symptoms, rescue medication use, and 
acute health care use among preschool asth-
matic children living in inner-city Baltimore. 
We selected a population of inner-city, pre-
dominantly minority children as a potentially 
susceptible subpopulation.
Materials and Methods
Study design. The Baltimore Indoor 
Environmental Study of Asthma in Kids 
is a longitudinal study that was designed 
to investigate the role of indoor pollutants 
and allergens on asthma (Diette et al. 2007; 
Matsui et al. 2006). We evaluated partici-
pating children at baseline and at 3 and 6 
months. At each time interval, environmental 
monitoring occurred for 3 consecutive days, 
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Ba c k g r o u n d: Although outdoor particulate matter (PM) has been linked to mortality and asthma 
morbidity, the impact of indoor PM on asthma has not been well established.
oB j e c t i v e: This study was designed to investigate the effect of in-home PM on asthma morbidity.
Me t h o d s : For a cohort of 150 asthmatic children (2–6 years of age) from Baltimore, Maryland, a tech-
nician deployed environmental monitoring equipment in the children’s bedrooms for 3-day intervals at 
baseline and at 3 and 6 months. Caregivers completed questionnaires and daily diaries during air sam-
pling. Longitudinal data analyses included regression models with generalized estimating equations.
re s u l t s: Children were primarily African Americans (91%) from lower socioeconomic back-
grounds and spent most of their time in the home. Mean (± SD) indoor PM2.5–10 (PM with aero-
dynamic diameter 2.5–10 µm) and PM2.5 (aerodynamic diameter < 2.5 µm) concentrations were 
17.4 ± 21.0 and 40.3 ± 35.4 µg/m3. In adjusted models, 10-µg/m3 increases in indoor PM2.5–10 
and PM2.5 were associated with increased incidences of asthma symptoms: 6% [95% confidence 
interval (CI), 1 to 12%] and 3% (95% CI, –1 to 7%), respectively; symptoms causing children to 
slow down: 8% (95% CI, 2 to 14%) and 4% (95% CI, 0 to 9%), respectively; nocturnal symptoms: 
8% (95% CI, 1 to 14%) and 6% (95% CI, 1 to 10%), respectively; wheezing that limited speech: 
11% (95% CI, 3 to 19%) and 7% (95% CI, 0 to 14%), respectively; and use of rescue medication: 
6% (95% CI, 1 to 10%) and 4% (95% CI, 1 to 8%), respectively. Increases of 10 µg/m3 in indoor 
and ambient PM2.5 were associated with 7% (95% CI, 2 to 11%) and 26% (95% CI, 1 to 52%) 
increases in exercise-related symptoms, respectively. 
co n c l u s i o n s: Among preschool asthmatic children in Baltimore, increases in in-home PM2.5–10 
and PM2.5 were associated with respiratory symptoms and rescue medication use. Increases in in-
home and ambient PM2.5 were associated with exercise-related symptoms. Although reducing PM 
outdoors may decrease asthma morbidity, reducing PM indoors, especially in homes of inner-city 
children, may lead to improved asthma health.
key w o r d s : air pollution, asthma, indoor, particulate matter, pediatric, urban. Environ Health Perspect 
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and we assessed health outcomes through 
caregiver report. The Johns Hopkins Medical 
Institutional Review Board approved the 
study, and all participants provided informed 
consent before beginning the study.
Participants. Recruitment for this study 
began in September 2001, and we completed 
the last follow-up visit in April 2004. We 
recruited participants from the health systems 
that provide care to most residents of East 
Baltimore, Maryland. To ascertain the diagno-
sis of asthma, we used a two-stage process. We 
identified children as potentially eligible if they 
had a health care encounter for asthma with an 
ICD-9 [International Classification of Diseases, 
9th Revision (World Health Organization 
1975)] code of 493.X in the previous 
12 months. To confirm the diagnosis, par-
ticipants had to report a physician diagnosis of 
asthma and had to have symptoms of asthma 
and/or medication use for asthma in the previ-
ous 6 months. Other inclusion criteria were 
age between 2 and 6 years and residence within 
one of nine contiguous ZIP codes within East 
Baltimore. Based on 2000 U.S. Census data, 
the ZIP codes of homes included in the study 
represented a geographic region that is > 99% 
urban (U.S. Census Bureau 2000).
Air quality assessment. A trained envi-
ronmental technician completed home visits. 
We conducted environmental monitoring at 
baseline and at 3 and 6 months. At each time 
period, we performed integrated air sampling 
in the child’s bedroom over a 3-day period. 
We chose the child’s bedroom as the indoor 
monitoring site because the bedroom rep-
resents an environment where we expected 
the child to spend a substantial portion of 
time while indoors. We conducted air sam-
pling continuously over 72 hr using PM10 
and PM2.5 4 L/min MSP impactors (St. Paul, 
MN) loaded with 37-mm, 2.0-µm pore-size, 
Teflo polytetrafluoroethylene membrane fil-
ters with polypropylene support rings (Pall 
Corporation, Ann Arbor, MI). We calculated 
coarse PM fraction as the difference between 
PM10 and PM2.5, a method that has been com-
monly used to assess coarse PM concentrations 
(Brunekreef and Forsberg 2005; Vanderpool 
et al. 2004). Inlet flow rates were calibrated 
at the beginning and end of each sampling 
period using primary standards (DryCal; 
Bios International Corporation, Butler, NJ). 
PM gravimetric analysis was conducted on a 
Mettler T5 microbalance (Mettler Toledo, 
Inc., Columbus, OH), after filters were pre-
equilibrated for 24 hr at constant temperature 
and humidity. We measured in-home tem-
perature and humidity concurrently using a 
HOBO temperature and humidity data logger 
(Onset Corporation, Pocasset, MA). We meas-
ured ambient PM for the study at a central site 
located within the study area using standard 
methods (U.S. EPA 1997). All homes were 
within 2 miles of the central monitoring site. 
PM2.5 was collected using the PM2.5 Partisol-
Plus model 2025 FRM sequential air sampler 
(Rupprecht & Patashnick Co. Inc., Albany, 
NY) and PM10 using a tapered element oscil-
lating microbalance (TEOM 1400; Rupprecht 
& Patashnick). For this analysis, when ambi-
ent values were missing from the central site, 
values were supplemented from the Maryland 
Department of the Environment Old Town 
Station, a reporting site for the U.S. EPA 
ambient air monitoring network that is within 
1 mile of the central monitoring site (U.S. 
EPA 2006a).
Clinical evaluation. We evaluated par-
ticipants at baseline and at 3 and 6 months. 
During the baseline clinic visit, each child 
underwent skin prick testing (Multi-Test II; 
Lincoln Diagnostics, Decatur, IL) to 14 aero-
allergens: American and German cockroach, 
dust mite mix, cat dander, dog hair/dander, 
mouse epithelia, rat epithelia, three pollens 
(Eastern Oak mix, grass mix, ragweed mix), 
and four molds (Helminthosporium, Alternaria, 
Penicillium, and Aspergillus). Atopy was defined 
as at least one positive skin test result to the 
panel of allergens tested. 
Once during each of the three monitoring 
periods, caregivers completed a health ques-
tionnaire that included closed-ended questions 
from the International Study of Asthma and 
Allergies in Childhood (Asher et al. 1995) 
and the Children’s Health Survey for Asthma 
(Asmussen et al. 1999) to evaluate indica-
tors of asthma health. Questions ascertained 
information about acute health care use in the 
prior 3 months (emergency department visits, 
unscheduled doctor visits, and hospitaliza-
tions) and days of rescue medication use in the 
previous 2 weeks (short-acting beta agonist). 
We also asked caregivers about the child’s 
symptoms in the previous 2 weeks, includ-
ing a) wheezing, coughing, or tightness in the 
chest; b) the need to slow down or stop activi-
ties because of asthma symptoms; c) wheezing 
so badly that the child could only speak one or 
two words at a time between breaths; d) symp-
toms with exercise; and e) nocturnal symp-
toms. We quantified each symptom as the 
number of days that the symptom was present 
in the previous 2 weeks (0–14 days). 
Caregivers also completed a daily activity 
diary that detailed activities that occurred in 
the home during three time periods, morning 
(6000–1200 hours), afternoon (1200–1800 
hours), and evening (1800–0600 hours). They 
recorded the number of windows that were 
open for > 10 min during each of these time 
periods. Caregivers also recorded the time 
that the child spent in the home, including 
the room where the environmental monitors 
were placed, in the daily diary.
Statistical analysis. We generated sum-
mary statistics using means or proportions, as 
appropriate. We made comparisons using the 
chi-square test for proportions and Student’s 
t-test for continuous data. We used negative 
binomial regression models with generalized 
estimating equations (GEE) (Zeger and Liang 
1986) to model the relationship between 
3-day average PM and three repeated mea-
sures of days of symptoms or rescue medica-
tion use during the previous 2 weeks. We used 
logistic regression models with GEE to model 
the relationship between PM concentration 
and odds of an acute health care encounter 
(hospitalization, emergency department visit, 
and unscheduled doctor visit). We constructed 
multivariate models to account for potential 
confounders that we identified based on a 
known relationship with asthma or with PM, 
or based on a statistically significant associa-
tion with either, in bivariate analyses. These 
covariates included age, sex, race, parent edu-
cation level, season, and ambient PM. The 
number of open windows in the home was 
not included in the final multivariate models 
because the addition of this variable had no 
substantial effect on the results. We performed 
all analyses with StataSE statistical software 
(version 8.0; StataCorp, College Station, TX). 
Statistical significance was defined as p < 0.05.
Results
The 150 children were between 2 and 6 years 
of age and were predominantly African 
American (91%) and from households of low 
socioeconomic status (Table 1). More than 
two-thirds of the children were atopic. The 
children had evidence of active asthma symp-
toms (Table 2), and 62% met classification 
criteria for persistent asthma (National Heart, 
Lung, and Blood Institute 1997, 2002). 
Children spent, on average, 14 of every 24 hr 
in their homes, and approximately half of this 
time they spent in the room where the envi-
ronmental monitoring occurred.
Characteristics of the PM measured 
indoors. The mean (± SD) concentration for 
indoor PM2.5–10 was 17.4 ± 21.1 µg/m3, and 
for PM2.5 was 40.3 ± 35.4 µg/m3. The mean 
indoor PM2.5 concentrations did not differ 
Table 1. Participant characteristics (n = 150).
Characteristic  Value
Age [years; mean (range)]  4.4 (2–6)
Race (%) 
  African American  91
  Caucasian  5
  Other  4
Sex (% male)  58
Caregiver education level (%) 
  Eighth grade/some high school  38
  High school   43
  Some college  19
Health insurance (%) 
  Public  89
  Private  9
  Self-pay  2McCormack et al.
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significantly by season (summer, 37.6 ± 31.6 
µg/m3; fall, 40.2 ± 33.3 µg/m3; winter, 40.2 
± 39.7 µg/m3; spring, 42.7 ± 36.6 µg/m3; p 
= 0.65). The mean indoor PM2.5–10 concen-
trations were significantly lower in the sum-
mer (12.83 ± 14.90 µg/m3) compared with 
the other seasons (fall, 18.14 ± 18.22 µg/m3; 
winter, 16.16 ± 12.19 µg/m3; spring, 20.85 ± 
30.91 µg/m3; p < 0.01). The in-home PM2.5–10 
and PM2.5 concentrations were significantly 
higher than the respective average ambient 
measurements made over the same time period 
(10.3 ± 21.0 µg/m3 and 12.4 ± 6.2; p < 0.01 for 
both comparisons) (Figure 1).
Effects of coarse PM on asthma health. 
Higher concentrations of coarse PM meas-
ured indoors were associated with substantial 
increases in asthma symptoms in both the 
bi  variate and the multivariate models (Tables 3, 
4). For example, for every 10-ug/m3 increase in 
indoor PM2.5–10 concentration, there was a 6% 
[95% confidence interval (CI), 1 to 12%; p = 
0.02] increase in the number of days of cough, 
wheeze, or chest tightness, after adjusting for 
age, race, sex, socioeconomic status, season, 
indoor fine PM, and ambient fine and coarse 
PM concentrations. In the adjusted models, 
higher indoor coarse PM concentration was 
also significantly associated with symptoms 
severe enough to slow a child’s activity, with 
wheezing that limited speaking ability, and with 
nocturnal symptoms with an 8% (95% CI, 
2 to 14%; p = 0.01), an 11% (95% CI, 3 to 
19%; p < 0.01), and an 8% (95% CI, 1 to 14; 
p = 0.02) increase in symptom days per 10-ug/
m3 increase in PM2.5–10, respectively. For every 
10-ug/m3 increase in PM2.5–10, there was a 6% 
(95% CI, 1 to 10%; p = 0.02) increase in days 
of rescue medication use, after adjusting for 
potential confounders. We found no signifi-
cant associations between PM2.5–10 measured 
indoors and acute health care use, as measured 
by emergency department visits, unsched-
uled doctor visits, and hospitalizations (data 
not shown). Ambient PM2.5–10 was not sig-
nificantly associated with respiratory symptoms, 
rescue medication use, or acute health care use 
in multi  variate analyses adjusting for simultane-
ously measured indoor PM (data not shown).
Effects of fine PM on asthma health. Fine 
PM was also positively associated with respi-
ratory symptoms and with rescue medica-
tion use (Tables 3 and 4). For example, for 
every 10-µg/m3 increase in PM2.5 measured 
indoors, there was a 7% (95% CI, 0 to 14%; 
p = 0.04) increase in days of wheezing severe 
enough to limit speech and a 4% (95% CI, 
1 to 8%; p = 0.04) increase in days on which 
rescue medication was needed, after adjust-
ment for potential confounders. We found 
no significant associations between in-home 
or ambient PM2.5 concentrations and acute 
health care use (data not shown).
Effects of PM on exercise-related symp-
toms. Both indoor and ambient fine PM 
concentrations were associated with exercise-
related respiratory symptoms. In the bivariate 
models, for every 10-µg/m3 increase in indoor 
and ambient PM2.5, there was a 4% (95% 
CI, 1 to 7%; p = 0.04) and a 15% (95% 
CI, –4 to 35%; p = 0.13) increase in days of 
exercise-related symptoms, respectively. In 
the multivariate models adjusting for partici-
pant characteristics that were potential con-
founders as well as for simultaneous indoor 
and ambient coarse PM, for every 10-µg/m3 
increase in indoor and ambient PM2.5, there 
was a 7% (95% CI, 2 to 11%; p < 0.01) and 
a 26% (95% CI, 1 to 52%; p = 0.04) increase 
in days of exercise-related symptoms, respec-
tively. In contrast, neither indoor nor ambi-
ent coarse PM concentrations were associated 
with exercise-related symptoms.
Discussion
Among inner-city children, most of whom 
were African American, we found that PM 
concentrations measured indoors were signifi-
cantly associated with asthma symptoms and 
rescue medication use. In our cohort, indoor 
fine and coarse PM concentrations were associ-
ated with increases in respiratory symptoms 
that were clinically significant in terms of their 
magnitude. For example, a 10-µg/m3 increase 
in PM2.5–10 concentration was associated with 
an 8% increased incidence in days of symptoms 
severe enough to slow a child’s activity.
Our findings are consistent with what is 
known about the effects of indoor PM on 
childhood asthma and provide new evidence 
of a detrimental health effect of indoor coarse 
PM. In a previous study, Delfino et al. (2004) 
investigated PM exposures among 19 school-
age children with asthma living in California 
and found that forced expiratory volume in 
1 sec was inversely associated with personal, 
indoor, and ambient PM2.5 and PM10. They 
found stronger associations with indoor than 
with ambient PM concentrations among these 
children but did not evaluate the effects of 
PM on symptoms or medication use. Studies 
of school-age children in Seattle, Washington, 
have shown that indoor PM2.5 exposure was 
associated with decreased pulmonary func-
tion in a subgroup of 11 children not taking 
inhaled corticosteroids, but these studies did 
not include indoor measurements of PM2.5–
10 (Koenig et al. 2005; Trenga et al. 2006). 
Thus, the present study, which includes a 
much larger sample size compared with previ-
ous studies, adds to the growing evidence that 
indoor PM exposure adversely affects asthma 
health and provides for the first time evidence 
that exposure to the indoor coarse (PM2.5–10) 
fraction is harmful for children with asthma, 
especially those of preschool age.
Our findings demonstrate that both indoor 
coarse and fine PM distinctly affect respiratory 
health. There are physiologic reasons that can 
explain why PM of these different size fractions 
can contribute separately to asthma morbidity. 
In vitro studies have shown that coarse PM 
preferentially induces inflammatory mediators 
in bronchial epithelial cells and alveolar mac-
rophages compared with fine PM and that bac-
terial and endotoxin components of coarse PM 
may play a key role in this process (Becker et al. 
Table 2. Baseline asthma status.
Characteristic  Value
Atopic (%)  69
Acute care use in the past 3 months (%)
  Emergency department visit   24
  Hospitalization  3
  Unscheduled doctor visit  18
Days of symptoms in the past 2 weeks (mean ± SD) 
  Cough, wheezing, chest tightness  2.16 ± 3.37
  Slow down because of symptoms  1.92 ± 3.79
  Symptoms with running  1.60 ± 3.13
  Nocturnal symptoms  1.69 ± 3.49
  Limited speech  0.33 ± 1.20
Days of rescue medication use in the 
  previous 2 weeks (mean ± SD)  3.77 ± 5.19
Figure 1. Indoor and ambient concentrations of PM2.5–10 (A) and PM2.5 (B). Boxes show the interquartile 
range (IQR), and the heavy dark lines are the median values. Whiskers represent the closest value within 
1.5 times the IQR. Indoor PM concentrations were significantly higher than simultaneously measured ambi-
ent concentrations. The dashed line (B) indicates the U.S. EPA annual limit for ambient PM2.5. Eighty-five 
percent of homes had indoor PM2.5 concentrations that exceeded this ambient limit. There are currently no 
standards for ambient coarse PM. Asterisks indicate positive outliers, with values up to 288 µg/m3 for indoor 
PM2.5–10 (A; n = 24) and up to 216 µg/m3 for indoor PM2.5 (B; n = 27).
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2003, 2005). Although fine PM may be capa-
ble of reaching the alveoli, regions responsible 
for gas exchange, the deposition of coarse PM 
in conducting airways and subsequent bron-
chial hyperreactivity may be driving the symp-
tomatic response measured in these preschool 
children. Although analyzing the composition 
of the PM and investigating the mechanism 
by which PM exacerbates asthma are beyond 
the scope of the present investigation, fine and 
coarse PM are known to have different sources, 
compositions, and deposition patterns in the 
respiratory tract, all of which may contribute 
to the differential health effects reported in 
our study. Understanding the components of 
indoor PM and the mechanism by which PM 
exacerbates asthma will be an important focus 
of future studies.
The strong relationship between indoor 
and ambient fine PM exposure and exercise-
related symptoms was striking. Previous 
investigators have suggested that exercise may 
play a role in asthma by modifying the effect 
of environmental stimuli and pollutants. In a 
study of asthmatic children, McConnell et al. 
(2003) found that nitrogen dioxide was asso-
ciated with bronchitic symptoms only among 
children participating in team sports. The 
authors hypothesized that the increased min-
ute ventilation may in part explain why the 
effect of NO2 was modified by exercise. Our 
findings of increased exercise symptoms in 
response to fine PM exposure may be attrib-
utable to increased minute ventilation and an 
increased dose of fine PM in the distal airways 
and the pulmonary circulation that is more 
potent in eliciting exercise-related symptoms 
than the doses of coarse PM that deposit in 
the more proximal airways.
The study population is a key strength 
of our study design. We were able to enroll a 
study population of predominantly African-
American, inner-city children who spent a sub-
stantial portion of time in their homes. Our 
results may provide insight about a potentially 
important contributor to the high burden of 
asthma in this population. African Americans 
are more likely than whites to live in geographic 
regions with poor outdoor air quality. For 
example, in 2002, 71% of African Americans 
lived in counties that violated federal air pol-
lution standards, compared with 58% of the 
white population (American Lung Association 
2005). Suboptimal indoor environments may 
contribute additional risk beyond that of the 
poor outdoor air quality. In Baltimore, a previ-
ous study has demonstrated that among chil-
dren with asthma, those living in the inner 
city had in-home PM concentrations that were 
two to three times greater than did those in the 
local suburbs (Simons et al. 2007). Compared 
with what is considered acceptable quality for 
outdoor air, the children in the present study 
lived in homes with relatively elevated PM con-
centrations. For example, 85% of children lived 
in homes that would fail to meet the NAAQS 
annual standard for acceptable ambient air 
quality and 55% lived in homes that would 
fail to meet the more stringent 24-hr standard 
(U.S. EPA 1997). We have demonstrated 
that PM concentrations in the indoor air are 
associated with additional asthma morbidity 
after controlling for the effects of ambient PM 
measured simultaneously. Thus, indoor PM 
exposure may be an important contributor to 
the disproportionate burden of disease among 
African Americans living in inner cities.
Avoidance of harmful environmental 
exposures is a key component of national and 
international guideline recommendations for 
management of asthma (Global Initiative for 
Asthma 2006; National Heart, Lung, and 
Blood Institute 2007). Guidelines identify PM 
as a pollutant of concern, but specific recom-
mendations are limited and focus mostly on 
avoiding exposure to elevated outdoor con-
centrations. This approach may imply that the 
indoor environment confers an advantage of 
lower exposure. However, our results dem-
onstrate that the indoor environment may be 
less favorable in some circumstances. Although 
some previous studies have found indoor PM 
concentrations that are similar to or lower than 
outdoor concentrations (Koenig et al. 2005; 
Turpin et al. 2007), our findings are consistent 
with previous studies that have demonstrated 
indoor PM concentrations that greatly exceed 
outdoor concentrations (Breysse et al. 2005; 
Keeler et al. 2002; Wallace 1996; Wallace et al. 
2003). Current recommendations for improv-
ing home indoor air quality focus mostly on 
avoidance of indoor environmental tobacco 
smoke. However, there are other important 
modifiable sources of indoor PM, includ-
ing common cleaning and cooking activities 
(McCormack et al. 2008; Wallace et al. 2003). 
In urban environments especially, penetration 
of outdoor air, which contains traffic-related 
PM, into the indoors may also be an important 
contributor to the composition of the indoor 
air (Turpin et al. 2007). In the present study, 
the homes were all in the inner city, and most 
were close to the road, making exposure to 
traffic-related urban dust a likely contribut-
ing factor to the composition of PM in most 
homes. Thus, our results are most generalizable 
to populations of children who live in urban 
settings. Although our study cannot determine 
which sources of indoor PM are responsible for 
exacerbating asthma symptoms, previous stud-
ies have shown that PM concentrations can be 
lowered indoors (Eggleston et al. 2005). Such 
studies have shown that a multifaceted indoor 
environmental control approach can reduce 
asthma morbidity, but the independent effect 
of PM reduction has not yet been determined 
(Eggleston et al. 2005; Morgan et al. 2004). 
Intervention studies to assess the impact of 
improving indoor air quality on asthma symp-
toms and which PM reduction methods are 
most beneficial will be critical to provide data 
to inform guidelines and policy initiatives.
A limitation of this study is the potential 
for measurement error. Although the study 
area was relatively homogeneous, and all homes 
were within 2 miles of the central monitoring 
site, we took estimates of outdoor PM expo-
sure from a central monitoring site rather than 
outdoor monitoring at the individual home. 
This approach could have resulted in nondif-
ferential measurement error and may have con-
tributed to the lack of a significant health effect 
of ambient PM exposure on non-exercise-
related symptoms. The methods of sampling 
indoor, and ambient air differed and although 
we did not conduct side-by-side comparisons, 
Table 4. Indoor PM concentrations, asthma symptoms, and rescue medication use: multivariate models.
  PM2.5–10 (per 10 µg/m3 increase)a  PM2.5 (per 10 µg/m3 increase)b
Symptom  IRR (95% CI)  p-Value  IRR (95% CI)  p-Value
Cough, wheezing, chest tightness  1.06 (1.01–1.12)  0.02  1.03 (0.99–1.07)  0.18
Slow down  1.08 (1.02–1.14)  0.01  1.04 (1.0–1.09)  0.06
Symptoms with running  1.00 (0.94–1.08)  0.81  1.07 (1.02–1.11)  < 0.01
Nocturnal symptoms  1.08 (1.01–1.14)  0.02  1.06 (1.01–1.10)  0.01
Limited speech  1.11 (1.03–1.19)  < 0.01  1.07 (1.00–1.14)  0.04
Rescue medication use  1.06 (1.01–1.10)  0.02  1.04 (1.01–1.08)  0.04
IRR, incidence rate ratio.
aAdjusted for age, sex, race, parent education level, season, indoor fine PM, ambient fine PM, ambient coarse PM. 
  bAdjusted for age, sex, race, parent education level, season, indoor coarse PM, ambient coarse PM, ambient fine PM. 
Table 3. Indoor PM concentrations, asthma symptoms, and rescue medication use: bivariate models.
  PM2.5–10 (per 10-µg/m3 increase)  PM2.5 (per 10-µg/m3 increase)
Symptom  IRR (95% CI)  p-Value  IRR (95% CI)  p-Value
Cough, wheezing, chest tightness  1.05 (0.99–1.10)  0.08  1.01 (0.98–1.05)  0.41
Slow down  1.08 (1.03–1.13)  < 0.01  1.00 (0.97–1.04)  0.85
Symptoms with running  1.03 (0.97–1.09)  0.39  1.04 (1.01–1.07)  0.04
Nocturnal symptoms  1.06 (1.01–1.11)  0.03  1.02 (0.98–1.05)  0.37
Limited speech  1.11 (1.05–1.18)  < 0.01  1.01 (0.95–1.07)  0.33
Rescue medication use  1.06 (1.02–1.11)  < 0.01  1.03 (1.00–1.6)  0.06
IRR, incidence rate ratio.McCormack et al.
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systematic differences of up to 17% have been 
previously reported (Williams et al. 2000). We 
obtained the PM2.5–10 concentrations by sub-
tracting PM 2.5 concentrations from PM10, 
making the PM2.5–10 measurement subject to 
greater error than either individual measure-
ment. We determined that the precision of 
the indoor PM2.5 and PM10 measures, deter-
mined by collocated samplers, were ±7% and 
±6%, respectively, resulting in an expected 
error in PM2.5–10 of 9%, which is consistent 
with the precision described previously (Chen 
et al. 2007; Vanderpool et al. 2004; Williams 
et al. 2000). Importantly, we conducted envi-
ronmental monitoring in the same manner 
for all study participants and did not differ 
it based on asthma status. Thus, nondiffer-
ential measurement error would be expected 
to bias our results toward the null and would 
not be responsible for the observed associa-
tion between indoor PM concentrations and 
asthma symptoms in this study.
In the present longitudinal study, fine and 
coarse PM concentrations measured indoors 
were associated with increased asthma mor-
bidity, including more frequent respiratory 
symptoms and rescue medication use, among 
inner-city minority children. Although the 
present study cannot delineate which sources 
of PM measured indoors were responsible for 
the observed health effects, these findings sug-
gest that improving air quality in the indoor 
environment with a strategy that reduces PM 
concentration may improve asthma health. 
These findings do not negate the importance 
of optimizing outdoor air quality, because 
outdoor PM concentrations are linked to 
adverse health effects, especially among those 
with underlying pulmonary disease, and out-
door air is an important determinant of the 
composition of indoor air. Instead, improv-
ing indoor air quality and lowering indoor 
PM concentrations may provide an additional 
means of improving asthma health, especially 
among children living in inner cities.
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